<?xml version="1.0" encoding="UTF-8"?>
<p id="p0145">VLA1601 is a purified, inactivated, whole-virus, alum-adsorbed vaccine being tested inÂ flavivirus-naive adults (
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT03425149" id="intref0055" xmlns:xlink="http://www.w3.org/1999/xlink">NCT03425149</ext-link>). Early study results indicate that the vaccine elicits neutralizing antibodies in a dose- and schedule-dependent manner.
 <xref rid="bib80" ref-type="bibr">
  <sup>80</sup>
 </xref> This vaccine was developed using the same platform as the IXIARO Japanese encephalitis vaccine.
</p>
